RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma. [electronic resource]
Producer: 20160505Description: 1939-50 p. digitalISSN:- 1538-8514
- Animals
- Antibiotics, Antineoplastic -- pharmacology
- Carcinoma, Squamous Cell -- drug therapy
- Cell Line, Tumor
- Disease Models, Animal
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- E2F7 Transcription Factor -- genetics
- Female
- GTPase-Activating Proteins -- genetics
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Guanosine Triphosphate -- metabolism
- Humans
- Mice
- Phosphatidylinositol 3-Kinases -- metabolism
- Prognosis
- Proto-Oncogene Proteins c-akt -- metabolism
- rac1 GTP-Binding Protein -- metabolism
- rhoA GTP-Binding Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.